Menu Search
Equities

Sabra Health Care REIT Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SBC:FRA

Sabra Health Care REIT Inc

Actions
  • Price (EUR)16.94
  • Today's Change0.253 / 1.52%
  • Shares traded240.00
  • 1 Year change+9.40%
  • Beta0.6291
Data delayed at least 15 minutes, as of Feb 13 2026 09:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Its investment portfolio primarily comprises skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed); investments in joint ventures; loans receivable, and preferred equity investments. Its real estate properties held for investment included 37,047 beds/units, spread across the United States and Canada.

  • Revenue in USD (TTM)774.63m
  • Net income in USD155.61m
  • Incorporated2010
  • Employees58.00
  • Location
    Sabra Health Care REIT Inc1781 FLIGHT WAYTUSTIN 92782United StatesUSA
  • Phone+1 (888) 393-8248
  • Fax+1 (949) 679-8868
  • Websitehttps://sabrahealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.